ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye Disease

ClinicalTrials.gov ID: NCT04583735

Public ClinicalTrials.gov record NCT04583735. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 4:14 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 4, Randomized, Double-masked, Placebo-controlled, Multicenter Trial to Evaluate the Efficacy and Safety of TEPEZZA® in Treating Patients With Chronic (Inactive) Thyroid Eye Disease

Study identification

NCT ID
NCT04583735
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Amgen
Industry
Enrollment
62 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • TEPEZZA Biological

Drug · Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 1, 2021
Primary completion
Mar 16, 2023
Completion
Oct 11, 2023
Last update posted
Jun 30, 2024

2021 – 2023

United States locations

U.S. sites
12
U.S. states
10
U.S. cities
12
Facility City State ZIP Site status
The Private Practice of Raymond Douglas Beverly Hills California 90210
Perlman Medical Offices / UCSD La Jolla California 92037
MACRO Trials Los Angeles California 90048
Univ of Colorado Dept of Ophthalmology Aurora Colorado 80045
Bascom Palmer Eye Institute / Univ of Miami Miami Florida 33136
Mayo Clinic Rochester Minnesota 55905
Washington University St Louis Missouri 63108
Las Vegas Endocrinology Las Vegas Nevada 89074
Endocrinology Specialists & Thyroid Center Greenville South Carolina 29605
Hamilton Eye Institute / U Tennessee Memphis Tennessee 38163
Neuro-Eye Clinical Trials Houston Texas 77401
Medical College of Wisconsin Milwaukee Wisconsin 52336

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04583735, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 30, 2024 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04583735 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →